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Many genome-wide association studies have been performed on progression towards the
acquired immune deficiency syndrome (AIDS) and they mainly identified associations within
the HLA loci. In this study, we demonstrate that the integration of biological information,
namely gene expression data, can enhance the sensitivity of genetic studies to unravel new
genetic associations relevant to AIDS.
Methods
We collated the biological information compiled from three databases of expression quanti-
tative trait loci (eQTLs) involved in cells of the immune system. We derived a list of single
nucleotide polymorphisms (SNPs) that are functional in that they correlate with differential
expression of genes in at least two of the databases. We tested the association of those
SNPs with AIDS progression in two cohorts, GRIV and ACS. Tests on permuted pheno-
types of the GRIV and ACS cohorts or on randomised sets of equivalent SNPs allowed us
to assess the statistical robustness of this method and to estimate the true positive rate.
Results
Eight genes were identified with high confidence (p = 0.001, rate of true positives 75%).
Some of those genes had previously been linked with HIV infection. Notably, ENTPD4
belongs to the same family as CD39, whose expression has already been associated with
AIDS progression; while DNAJB12 is part of the HSP90 pathway, which is involved in the
control of HIV latency. Our study also drew our attention to lesser-known functions such as
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mitochondrial ribosomal proteins and a zinc finger protein, ZFP57, which could be central to
the effectiveness of HIV infection. Interestingly, for six out of those eight genes, down-regu-
lation is associated with non-progression, which makes them appealing targets to develop
drugs against HIV.
Introduction
More than fifteen genome-wide association studies (GWAS) have been conducted on AIDS
since the seminal GWAS on HIV-1 progression in 2007 [1,2]. They mainly revealed associa-
tions in the region of the chromosome 6HLA loci [1,3,4], in particular a single nucleotide poly-
morphism (SNP) in theHCP5 gene, rs2395029. This SNP is in complete linkage disequilibrium
with the HLA-B5701 allele, already identified by several candidate-gene studies for its role in
non-progression and the control of viral load [5–7]. Candidate gene studies also contributed to
the discovery of another important polymorphisms, CCR5-Δ32 [8–10].
Most of the genetic association studies on AIDS have relied on endpoints such as viral load at
setpoint or time to reach a clinical symptom (e.g. CDCAIDS 1993 or death). The Genetics of Resis-
tance to Immunodeficiency Virus (GRIV) cohort, composed of extreme phenotypes, non-progres-
sors [11–13] and rapid progressors [14], is different since it relies on a case-control analysis.
For many human traits and diseases including AIDS, a substantial portion of heritability
remains unexplained [15,16]. Strategies to increase the number of novel findings are being
developed, including rare variants, facilitated by sequencing, or meta-analyses but with limited
success to date [17].
Another approach that has received considerable attention is the use of pathway-based asso-
ciation tests that aim to look for an enrichment of associations in sets of genes within the same
biological pathway [18–20]. Genetic association studies on AIDS have been described for spe-
cific pathways [21], but a systematic pathway analysis has yet to be performed. Increasingly
popular, expression quantitative trait loci (eQTLs) quantify the relationship between genetic
polymorphisms and gene transcription [22,23]. It has been proposed that eQTL are of the
utmost important in the development of pathological traits [24,25].
In the present work, we have developed a novel, general-purpose pipeline based on the use
of several eQTL databases as filters to preselect so-called functional SNPs. We used the data-
bases “GHS_Express” by [26], “Gene Expression Analysis Based on Imputed Genotype” by
[27], and “Genevar” by the Sanger Institute [28–30]. These databases correlate each SNP with
gene expression in a specific cell line. We preselected the SNPs exhibiting the most significant
p-values in each database, and to further warrant a prominent functional impact on gene
expression, we selected the ones concurrently found in two or three databases. This restricted
set of candidate functional SNPs was tested for genetic associations with AIDS using the GRIV
cohort of extreme progression to AIDS [4,11–14] and using the Amsterdam Cohort Studies
(ACS) cohort for replication [31]. As an added benefit, the eQTL databases allow us to directly
associate gene expression levels with AIDS progression.
This unique approach selects a few hundred candidate SNPs to be tested for genetic associa-
tion with AIDS, on the sole basis of their functional impact on gene expression, and it also dif-
fers from past candidate gene studies [32] since there was no gene pre-selection based on
specific knowledge of AIDS biology. In this article, we describe how this approach was success-
ful in unravelling novel, statistically-significant associations with biological activities particu-
larly relevant to HIV-1 infection.
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Results
Fig 1 shows a schematic overview of how we integrated eQTL data and progression towards
AIDS in two cohorts to draw new genetic associations.
Functional SNPs
We determined the modes of the associations between SNPs and gene transcription levels as
described in the Methods section and found: 16,000 additive associations, 2173 recessive asso-
ciations, 2050 dominant associations, 1133 overdominant associations, 3491 additive-or-domi-
nant associations and 682 additive-or-recessive associations. Ambiguous modes were
considered dominant for the remainder of the study, given the overwhelming majority of asso-
ciations is additive.
Using the threshold p = 10−4 and the additive mode for eQTLs, we obtained a set of 1788
SNP/gene pairs corresponding to 1706 distinct SNPs and 567 distinct genes. The set of SNP/
gene pairs is made of 73 pairs common to all three databases, 33 pairs common to Cambien
and Genevar only, 527 pairs common to Dixon and Genevar only and 1155 pairs common to
Cambien and Dixon only.
Linkage disequilibrium between those SNPs was removed. Pairs of SNPs with more than r2
 0.2 were identified using the Broad Institute’s ‘SNAP Pairwise LD’. (See S2 File for details).
Such pairs define a ‘linkage disequilibirum graph’, where SNPs are vertices and edges con-
nect SNPs in linkage disequilibrium. The connected components of this graph are calculated
and a representative SNP is chosen for each connected component (for convenience’s sake, we
chose the SNP with the lowest ID in dbSNP). Generally, though not always, consistent groups
of genes are regulated among the SNPs within a connected component. We obtain a set of 655
independent SNPs (see S1 Table).
Fig 1. Schematic summary of our methodology. The data from three databases are integrated to provide us with functional SNPs likely to be associated
with changes in gene transcription in the tissue of interest. Using the SNAP Pairwise LD server, we only kept independent SNPs by removing superfluous
SNPs that were in linkage disequilibrium (r2 0.2). Among those SNPs, associations with slow and non-progression towards AIDS are sought and
replicated. Randomisations are carried out in order to evaluate the statistical robustness of our results. Finally, the genetic associations are used to link
progression to AIDS and gene expression in candidate genes.
doi:10.1371/journal.pone.0136989.g001
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Genetic associations with AIDS progression
Of the 655 SNPs selected above, N = 654 could be imputed in GRIV and ACS cohorts and their
association with slow progression or non-progression to AIDS could be sought in GRIV and
replicated in ACS as described in the Methods section. Given that there was a small number of
SNPs to be tested and that we resorted to replication, a p-value of α = 0.05 was used both for
the association in the GRIV cohort and for the replication in the ACS cohort. With this choice,
a low type-I error was expected.
Genetic associations
Nine out of the 654 SNPs are associated with slow and non-progression towards AIDS (see
Table 1 and S1 File for the Q-Q plots). Which is more than the number of associations
expected by chance. We recalculated all the r2 values for the associations on chromosome 6 in
the DESIR cohort. All associations are at linkage equilibrium but one pair: rs3130350/
rs3749971 (r2 = 0.6, distance 985 kbp). These SNPs were not reported by the SNAP Pairwise
LD server because they are more than 500 kbp apart. The final number of independent associa-
tions is 8.
Statistical significance: estimation of the sensitivity
To demonstrate that the number of significant hits really arises from associations between
polymorphisms and the phenotypes, we carried out two sets of randomisations: (1) phenotype
randomisation to show that the choice of the functional SNPs is itself not sufficient to warrant
significant hits, (2) SNP randomisation to show that neither is the spectrum of phenotypes is.
Those randomisations come with the added benefit that we can estimate the false discovery
rate and its distribution (hence, of the sensitivity of our method). We carried out 1000 pheno-
type randomisations and 36 SNP randomisations (12 of which are sampled from the eQTL
databases). The results are shown in Fig 2.
The phenotype randomisations allow us to estimate two useful, complementary measures
from the distribution: the fraction of expected false positives (‘sensitivity’) and the likelihood of
Table 1. List of the significant associations (p 0.05) with slow and non-progression. Alleles, allele frequencies (AF), positional data and genetic
modes are provided with the results of the statistical inferences. Opposite signs for the β coefficients are required for an association to be replicated in the





Mode β (GRIV) p (GRIV) β (ACS) p (ACS) Allele associated with
non-progression
732563 T C 53% 8 23,488,013 additive -0.23 0.029 0.21 0.029 T
732563 T C 53% 8 23,488,013 recessive -0.41 0.024 0.40 0.007 T
2205418 T C 12% 21 28,657,885 recessive -2.24 0.038 2.81 1.510–4 T
2241335 C T 45% 7 134,294,616 dominant 0.44 0.015 -0.34 0.034 T
2242229 G T 78% 17 75,246,420 recessive 0.49 0.003 -0.33 0.025 T
2921446 C A 66% 10 72,691,727 dominant 0.53 0.037 -0.48 0.024 A
3130350 G T 7% 6 30,360,062 additive -0.66 0.019 0.51 0.001 G
3130350 G T 7% 6 30,360,062 dominant -0.73 0.015 0.42 0.010 G
3130501 A G 77% 6 31,168,676 dominant -0.78 0.021 0.81 0.038 A
3749971* G A 6% 6 29,374,998 dominant -0.67 0.036 0.37 0.031 G
4714580 A G 83% 6 42,206,820 recessive -0.32 0.049 0.33 0.045 A
(*) Note that rs3749971 is in linkage disequilibrium with rs3130350 and is therefore not considered an independent finding in our statistics (see text).
doi:10.1371/journal.pone.0136989.t001
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obtaining as many independent SNPs as we did or more by chance alone (p-value). The sensi-
tivity (true positives) is estimated at 75% (in other words 25% false discovery rate) with a 95%
credible interval of 38% to 100%. Under the null hypothesis, the probability of obtaining as
many independent SNPs as we did or more is p = 0.001.
Although their number is far lower than that of phenotype randomisations (due to technical
reasons, see Materials and Methods), SNP randomisations give results that are well aligned
with phenotype randomisations: the location and spread of the distributions cannot be
distinguished.
Regulated genes and biological significance
Wemapped the 8 SNPs back to the corresponding genes of the SNP/gene pairs identified ear-
lier and the direction of the correlation with each gene’s expression. This allowed us to associ-
ate gene expression with slow or non-progression to AIDS. The expression of the following
genes therefore could be important in progression towards AIDS: CCT8, DNAJB12, ENTPD4,
GUCA1B,HCG27,MRPS7,MRPS10, SLC35B4 and ZFP57. No additional gene was identified
by considering the connected components of the LD graph. The results are presented in
Table 2.
The ENTPD4 gene codes for a protein involved in the metabolism of purines and pyrimi-
dines. Our results suggest that down-regulation of ENTPD4 is associated with a slower
Fig 2. Statistical significance of our associations. Histogram of the number of SNPs that pass the
significance criterion for this study using phenotype and SNP randomisations. These results provide us with a
way to estimate the sensitivity of our study (diamond): it would be extremely unlikely for our eight independent
findings to arise by chance alone (p = 0.001).
doi:10.1371/journal.pone.0136989.g002
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progression to AIDS. It is known that CD39, a member of the ENTPD family, is the dominant
immune system ectonucleotidase that hydrolyses extracellular ATP and ADP into AMP at the
sites of immune activation. A previous study indicated that a down-regulated CD39 expression
in CD4 T cells was associated with a slower progression to AIDS [21,33]. Interestingly, the
ENTPD4 gene is among the genes significantly up-regulated (6-fold up-regulation) during anti-
gen presentation in CD4 T cells by the presence of HIV’s gp120/V3 peptides [34]. ENTPD4 is
also expressed in B lymphocytes [35] and GTEx data support a weak association between
rs2241335 and rs2241336 polymorphism and ENTPD4 expression levels (p = 0.1, N = 42) in
the cell line of EBV-transformed lymphocytes [22].
Interestingly, two nuclear genes coding for mitochondrial ribosomal proteins were found in
our study (MRPS7 on chromosome 17 andMRPS10 on chromosome 6). Somewhat surpris-
ingly, a lower transcription ofMRPS10 but a higher transcription ofMRPS7 are associated with
slow and non-progression towards AIDS. Although the involvement in AIDS progression of
those genes has never been reported, the implication of mitochondria in AIDS pathogenesis
has been suggested by several studies in the past. For example, genetic associations between
mitochondrial haplotypes and AIDS progression have been reported [36,37].MRPS12 was also
among 185 genes predictive of HIV-1 resistance and 29 infection information exchanger genes
[38]; as a consequence, Huang and colleagues speculated thatMRPS12 could be important for
the coordination of HIV infection. Furthermore, gene set analyses have suggested that mito-
chondria could be key in the immune response against HIV infections even though the exact
pathways (energy metabolism, cell apoptosis or cell cycle dysregulation) are yet to be identified
[39]. MRPS10 interacts with a number of proteins involved in HIV aetiology (see S1 File). An
association betweenMRPS7’s expression and rs2242229 is also reported in the Geuvadis data-
base (p = 3.4×10−23) [23].
The identification of DNAJB12 as a potentially important gene is reminiscent of the obser-
vation that the HSP40/DNAJ family proteins play a role in infection of various viruses. Urano
and colleagues identified DNAJ/HSP40B6 as a potential regulator of HIV-1 replication [40]. It
is an interesting finding considering the attention that another chaperone, namely HSP90, has
recently attracted: HSP90 could promote infectiousness of HIV by controlling HIV reactivation
from latency [41] and several inhibitors of HSP90 are currently in clinical development [42].
This is consistent with our observation that a lower expression of DNAJB12, which is part of
Table 2. List of SNP/gene pairs associated with AIDS progression. The genetic association is linked back to its association with gene expression levels
to provide an association between transcription levels (we use the word ‘regulation’ for convenience’s sake) and AIDS progression.
SNP Chromosome Gene Gene function Association with non-
progression
732563 8 ENTPD4 ectonucleoside triphosphate diphosphohydrolase 4 Down-regulation
2205418 21 CCT8 chaperonin containing TCP1, subunit 8 (theta) Down-regulation
2241335 7 SLC35B4 solute carrier family 35 (UDP-xylose/UDP-N-acetylglucosamine
transporter), member B4
Up-regulation
2242229 17 MRPS7 mitochondrial ribosomal protein S7 Up-regulation
2921446 10 DNAJB12 DnaJ (Hsp40) homolog, subfamily B, member 12 Down-regulation
3749971/
3130350
6 ZFP57 ZFP57 zinc finger protein Down-regulation
3130501 6 HCG27 HLA complex group 27 (non-protein coding) Down-regulation
4714580 6 GUCA1B guanylate cyclase activator 1B (retina) Down-regulation
4714580 6 MRPS10 mitochondrial ribosomal protein S10 Down-regulation
(*) Note that rs3749971 is in linkage disequilibrium with rs3130350 and is therefore not considered an independent finding (see text).
doi:10.1371/journal.pone.0136989.t002
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the HSP90 pathway [43], correlates with slow or non-progression towards AIDS. DNAJB12
also interacts with many proteins known to be associated with HIV infection: among the twelve
protein-protein interactions reported by InnateDB [44], eight proteins (DSTN, EGFR, HSPA8,
MME, MYC, SGTA and UBC) are also found in the HIV-1 Human Interaction Database [45]
(see S1 File). The association of low expression of chaperone-coding gene CCT8 with slow- and
non-progression also points to a role of chaperones in promoting HIV infection; also of interest
is the observation that CCT8 is one of the proteins to be differentially regulated in synapto-
somal isolates from HIV/gp120 transgenic mice [46]; an association between CCT8’s expres-
sion and rs2205418 is also reported in the Geuvadis database (p = 1.7×10−8) [23].
ZFP57 is a transcriptional regulator involved in DNA methylation and genomic imprinting
during development but its gene expression also occurs at in adult peripheral blood cells [47].
A lower transcription correlates with slow or non-progression towards AIDS. As reported by
Plant et al., SNPs associated with differential transcription of this gene have already been
highlighted as associated with AIDS progression [4,47,48]. The impact of ZFP57 could be due
to the promotion of viral latency through hypermethylation [47] or through its interaction
with TRIM28, which was shown to enhance HIV infections in model cell lines [49].
The gene HCG27 (HLA complex group 27) is a non-protein coding gene; thoughHLA
genes have been consistently been associated with AIDS progression [2,50], the role of this
gene (as well as that of other candidate genes revealed in this study, such as SLC35B4,
GUCA1B) is difficult to evaluate to the best of our knowledge. Note that GUCA1B could be a
passenger finding: indeed, it is the second of two genes whose expression correlates with the
rs4714580 polymorphism, the first beingMRPS10, which might be the causal gene.
Associations with rapid progression towards AIDS
Genetic associations with rapid progression towards AIDS were sought among the list of 654
functional SNPs. Our randomisation tests demonstrated that the associations were not statisti-
cally significant (see S1 File). This demonstrates that these randomisation procedures act as
effective safeguards against spurious associations.
Discussion
Genomewide association studies have successfully allowed the confident discovery of many
factors involved in human diseases. However, they haven’t yet told the whole story. In AIDS,
they have mostly yielded associations in theHLA region and in relation with the CCR5 region
[12]. Still, there obviously is a gap between our current ability to detect genetic associations and
our capacity to predict the risk based on genetics alone; the ‘missing heritability’ hints that
there remain difficult-to-identify genetic markers [15,51]. Larger cohorts are used to overcome
this [17] but another route consists in integrating data from various sources. This study pro-
vides a successful implementation of the second solution.
The rationale behind our work is that the integration of eQTL data provides us with a reli-
able SNP/gene map, not without similarities with the concept of ‘eSNP’ (genetic variants
directly associated with higher or lower transcript expression levels), which is more likely to
point towards functional and causal factors. Using three gene expression databases (GHS_Ex-
press, Gene Expression Analysis Based on Imputed Genotype and Genevar), we could identify
polymorphisms more likely to play a functional role. Our approach is substantiated by the
number of SNP/gene pairs confirmed in the GTEx and Geuvadis DBs. The randomisations
involving SNPs sampled from the eQTL databases highlight the value of integrating data from
several databases.
Gene Expression Profiles Associated with Non-Progression towards AIDS
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We looked for genetic associations in GRIV and replicated those in ACS and found eight
independent SNPs significantly associated with slow or non-progression to AIDS. An impor-
tant facet of this study was the evaluation of the statistical robustness of our findings, which
confidently supports a significant of positive associations.
eQTL databases were not only essential in the preparation of a carefully-selected set of func-
tional SNPs, they also were instrumental in identifying candidate genes whose expression pro-
files could be more directly associated with the AIDS progression phenotypes: ENTPD4, CCT8,
SLC35B4,MRPS7,MRPS10, DNAJB12, ZFP57,HCG27 and GUCA1B. Overall, we have found
in the existing literature and in published datasets compelling biological grounds for the possi-
ble implication of the genes identified in this study in progression to AIDS. Interestingly, for
six out of those eight genes, down-regulation is associated with non-progression, which makes
them appealing targets to combat HIV infections. Importantly, our study revealed a number of
yet uninvestigated candidate genes, which can further our understanding of AIDS infection
and AIDS progression as well as facilitate the discovery of new drugs.
Researchers working on other diseases could easily apply this method to their own genome-
wide datasets. The set of 655 functional SNPs is provided as S1 Table and is available from
http://www.griv.org/functSNPs/.
Materials and Methods
Sets of functional SNPs
In this work, we investigated associations between gene expression and AIDS progression. The
associations were sought through the selection of ‘functional SNPs’, known to be associated
with changes in gene transcription levels; informally, we can define a functional SNP as a SNP
likely to have a direct biological action through gene expression. We achieved this by integrat-
ing the data obtained from three separate mRNA-expression databases: GHS_Expression
(hereafter referred to as the ‘Cambien’ database) [26], Gene Expression Analysis Based on
Imputed Genotype (hereafter referred to as the ‘Dixon database) [27] and Genevar [28–30].
(See S2 File for details).
Data integration. Formally, a SNP s is considered functional if it meets the following crite-
rion: there exists a gene g such that the genotype of s consistently and significantly (reported p-
value is less than 10−4) correlates with the transcription levels of the gene g in at least two of the
three databases Cambien, Dixon and Genevar. This selection warrants high confidence in the
selection. The mode (additive) must be coherent throughout the datasets and the correlation
must be consistent including across different probes within a single dataset. The set of func-
tional SNPs is a list of elements ({S, s}, g,m, d, D), where {S, s} is a biallelic SNP (defined as a
major/minor pair of alleles), g is a gene,m is the mode in which the allele s is associated with an
altered expression of the gene g, d is the direction of regulation (+ or-) and D the datasets
where the regulation is observed (Cambien, Dixon or Genevar).
The threshold p< 10−4 was partly constrained by the fact that the Cambien database only
reports associations for which the p-value is less than 10−4 already. Had the data been complete,
other choices of threshold could have been made, provided the significance of the results could
be ascertained using the randomisations described below.
Cohorts
The Genomics of Resistance to Immunodeficiency Virus Cohort (GRIV) and the French
control group. The GRIV cohort, established in 1995 in France, is a collection of DNA sam-
ples used to identify host genes associated with slow progression and with rapid progression to
AIDS [7,10,52]. The study was reviewed and approved by the institutional review board of
Gene Expression Profiles Associated with Non-Progression towards AIDS
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Hôpital Saint-Louis (Paris, France) before the study began. All participants provided written
informed consent. Only white individuals of European descent living in France were eligible
for enrolment to reduce confounding effects by population substructure. These criteria limit
the influence of the ethnic and environmental factors (all subjects live in a similar environment
and are infected by HIV-1 subtype B strains) and put an emphasis on the genetic make-up of
each individual in determination of long term non-progression (NP) to AIDS. The NP group
(n = 270) was composed of 200 males and 70 females aged at inclusion from 19 to 62 (mean
age 35). We used the Data from an Epidemiological Study on Insulin Resistance Syndrome
(DESIR) program as a control group. (See S2 File for details).
The Amsterdam Cohort Studies Cohort (ACS). The ACS cohort was composed of 316
HIV-1 homosexual men. The study was reviewed and approved by the AMCMedical Ethics
Committee. All participants provided written informed consent. This cohort was established to
follow the course of HIV-1 infection using various endpoints related to HIV-1 infection and
AIDS [31,53].
Processing genomic data
We excluded individuals who were related and outliers based on population stratification.
SNPs were excluded when, within the control group, they were out of Hardy-Weinberg equilib-
rium, when the minor allelic frequency was less than 1% or when missing data were greater
than 2%. Individuals with more than 5% missing data or with high heterozygosity were
excluded.
In order to identify all the known SNPs in LD with our selected list of SNPs, present in the
HapMap database, we imputed all SNPs in the GRIV, ACS and control subjects using the 1000
Genomes phase I data [54]. Only the SNPs reliably imputed were retained.
The SNPs associated with non-progression towards AIDS were sought in the GRIV cohort
and then replicated in ACS. In order to be replicated an association must be consistent in
terms of its genetic mode and effect direction.
For each functional SNP, we computed the p-values of the association in the GRIV cohort
either with non-progression or with rapid progression using a standard case-control analysis
(non-progression vs control and rapid progression vs control). All modes (dominant, recessive,
and additive) were tested. Sex and the first two stratification axes were included as covariates.
The significance threshold for an association with progression was set at α = 0.05.
For each functional SNP, we computed the p-values of the association in the ACS cohort
with progression using the (censored) variable ‘time to AIDS 1993 after HIV-1 infection’ [10].
The first two stratification axes were included as covariates (sex was not included as all subjects
are male). (See S2 File for details).
Randomisation tests
Though the method described in this paper used expression data to investigate associations
between gene regulation and phenotypes, we assessed the significance of our findings at the
SNPs’ level. Indeed, there currently does not exist a method to randomise expression data
alongside genotypes. Therefore, the significance really tests the usability and robustness of the
concept of ‘functional SNP’ we have used in this study. The significance of our findings was
testing using two randomisation procedures: phenotype randomisation and SNP
randomisation.
Phenotype randomisation. In GRIV, the NP and control phenotypes were randomised
using GNU R’s sample function. In ACS, the ‘time to AIDS 1993’ variable was similarly
Gene Expression Profiles Associated with Non-Progression towards AIDS
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randomised using GNU R’s sample function; the corresponding censored status was carried
along during randomisation.
SNP randomisation. In order to avoid any bias, 36 sets of SNPs comparable to the set of
functional SNPs described above were selected for the SNP randomisation. SNP sets had to be
comparable in terms of allele frequency, genotyping/imputation ratio, linkage disequilibrium,
and distance to nearest gene. Other factors (sex, stratification principal components, outcome)
were maintained unaltered. Only 36 sets were produced: (1) given the constraints, the number
of sets is limited by nature, (2) SNP randomisation is computationally expensive than pheno-
type randomisation, (3) the distribution resulting from SNP randomisation is used to corrobo-
rate the distribution obtained using more extensive phenotype randomisation. (See S2 File for
details).
Supporting Information
S1 File. Supporting Results.Which eQTL database can the functional SNPs traced back to?
Q-Q plots for the analyses. Negative results for rapid progression. Interactions between the
identified genes and AIDS/HIV.
(PDF)
S2 File. Supporting Methods.Mode in the Cambien dataset. Additional details about the
cohorts. Workflow for preprocessing genomic data and testing the association with slow or
non-progression. Parameters for linkage disequilibrium. Details about the SNP randomisation.
(PDF)
S1 Table. List of functional SNPs. List of SNPs which with consistent behaviour in the three
eQTL databases used in this work.
(XLSX)
Acknowledgments
The authors are grateful to all the patients and medical staff who have kindly collaborated with
the genetic projects presented in this study, in particular to the contributors of the GRIV proj-
ect in France and of the ACS project in Netherlands.
Author Contributions
Conceived and designed the experiments: JFZ. Performed the experiments: SLC TL DvM HS.
Analyzed the data: PR JLS JN OD CC VL LT DUMM.Wrote the paper: PR JLS JFZ JN.
References
1. Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M, et al. A whole-genome association
study of major determinants for host control of HIV-1. Science. 2007; 317: 944–947. doi: 10.1126/
science.1143767 PMID: 17641165
2. Limou S, Zagury J-F. Immunogenetics: Genome-wide association of non-progressive HIV and viral
load control:HLA genes and beyond. Front Immunol. 2013; 4: 118. doi: 10.3389/fimmu.2013.00118
PMID: 23750159
3. Dalmasso C, Carpentier W, Meyer L, Rouzioux C, Goujard C, Chaix M-L, et al. Distinct genetic loci con-
trol plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: the ANRSGenomeWide Associa-
tion 01 study. PLoS ONE. 2008; 3: e3907. doi: 10.1371/journal.pone.0003907 PMID: 19107206
4. Limou S, Le Clerc S, Coulonges C, Carpentier W, Dina C, Delaneau O, et al. Genomewide association
study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRSGenome-
wide Association Study 02). J Infect Dis. 2009; 199: 419–426. doi: 10.1086/596067 PMID: 19115949
5. Carrington M, Nelson GW, Martin MP, Kissner T. HLA and HIV-1: heterozygote advantage and B*35-
Cw*04 disadvantage. Science. 1999. doi: 10.1126/science.283.5408.1748
Gene Expression Profiles Associated with Non-Progression towards AIDS
PLOSONE | DOI:10.1371/journal.pone.0136989 September 14, 2015 10 / 13
6. Hendel H, Caillat-Zucman S, Lebuanec H, Carrington M, O'Brien S, Andrieu JM, et al. New class I and
II HLA alleles strongly associated with opposite patterns of progression to AIDS. J Immunol. 1999; 162:
6942–6946. PMID: 10352317
7. Flores-Villanueva PO, Hendel H, Caillat-Zucman S, Rappaport J, Burgos-Tiburcio A, Bertin-Maghit S,
et al. Associations ofMHC ancestral haplotypes with resistance/susceptibility to AIDS disease develop-
ment. J Immunol. 2003; 170: 1925–1929. doi: 10.4049/jimmunol.170.4.1925 PMID: 12574360
8. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, et al. Genetic Restriction of HIV-
1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene. Science. 1996;
273: 1856–1862. doi: 10.1126/science.273.5283.1856 PMID: 8791590
9. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, et al. Resistance to HIV-1 infection
in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 1996;
382: 722–725. doi: 10.1038/382722a0 PMID: 8751444
10. Winkler CA, Hendel H, Carrington M, Smith MW, Nelson GW, O'Brien SJ, et al. Dominant effects of
CCR2-CCR5 haplotypes in HIV-1 disease progression. J Acquir Immune Defic Syndr. 2004; 37: 1534–
1538. PMID: 15602133
11. Le Clerc S, Coulonges C, Delaneau O, Van Manen D, Herbeck JT, Limou S, et al. Screening low-fre-
quency SNPs from genome-wide association study reveals a new risk allele for progression to AIDS. J
Acquir Immune Defic Syndr. 2011; 56: 279–284. PMID: 21107268
12. Limou S, Coulonges C, Herbeck JT, VanManen D, An P, Le Clerc S, et al. Multiple-cohort genetic asso-
ciation study reveals CXCR6 as a new chemokine receptor involved in long-term nonprogression to
AIDS. J Infect Dis. 2010; 202: 908–915. doi: 10.1086/655782 PMID: 20704485
13. Limou S, Delaneau O, Van Manen D, An P, Sezgin E, Le Clerc S, et al. Multicohort genomewide associ-
ation study reveals a new signal of protection against HIV-1 acquisition. J Infect Dis. 2012; 205: 1155–
1162. doi: 10.1093/infdis/jis028 PMID: 22362864
14. Le Clerc S, Limou S, Coulonges C, Carpentier W, Dina C, Taing L, et al. Genomewide association
study of a rapid progression cohort identifies new susceptibility alleles for AIDS (ANRSGenomewide
Association Study 03). J Infect Dis. 2009; 200: 1194–1201. doi: 10.1086/605892 PMID: 19754311
15. Maher B. Personal genomes: The case of the missing heritability. Nature. 2008; 456: 18–21. doi: 10.
1038/456018a PMID: 18987709
16. O'Brien SJ, Nelson GW. Human genes that limit AIDS. Nat Genet. 2004; 36: 565–574. doi: 10.1038/
ng1369 PMID: 15167933
17. McLaren PJ, Coulonges C, Ripke S, van den Berg L, Buchbinder S, Carrington M, et al. Association
study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls.
PLoS Pathog. 2013; 9: e1003515. doi: 10.1371/journal.ppat.1003515 PMID: 23935489
18. Cantor RM, Lange K, Sinsheimer JS. Prioritizing GWAS results: A review of statistical methods and rec-
ommendations for their application. Am J HumGenet. 2010; 86: 6–22. doi: 10.1016/j.ajhg.2009.11.017
PMID: 20074509
19. Eleftherohorinou H, Wright V, Hoggart C, Hartikainen A-L, Jarvelin M-R, Balding D, et al. Pathway anal-
ysis of GWAS provides new insights into genetic susceptibility to 3 inflammatory diseases. PLoS ONE.
2009; 4: e8068. doi: 10.1371/journal.pone.0008068 PMID: 19956648
20. Wang K, Li M, Hakonarson H. Analysing biological pathways in genome-wide association studies. Nat
Rev Genet. 2010; 11: 843–854. doi: 10.1038/nrg2884 PMID: 21085203
21. Nikolova M, Carriere M, Jenabian M-A, Limou S, Younas M, Kök A, et al. CD39/adenosine pathway is
involved in AIDS progression. PLoS Pathog. 2011; 7: e1002110. doi: 10.1371/journal.ppat.1002110
PMID: 21750674
22. GTEx Consortium. The Genotype-Tissue Expression (GTEx) project. Nat Genet. 2013; 45: 580–585.
doi: 10.1038/ng.2653 PMID: 23715323
23. Lappalainen T, Sammeth M, Friedländer MR, 't Hoen PAC, Monlong J, Rivas MA, et al. Transcriptome
and genome sequencing uncovers functional variation in humans. Nature. 2013; 501: 506–511. doi:
10.1038/nature12531 PMID: 24037378
24. Nicolae DL, Gamazon E, ZhangW, Duan S, Dolan ME, Cox NJ. Trait-associated SNPs are more likely
to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet. 2010; 6: e1000888. doi: 10.
1371/journal.pgen.1000888 PMID: 20369019
25. Kang M, Zhang C, Chun H-W, Ding C, Liu C, Gao J. eQTL epistasis: detecting epistatic effects and
inferring hierarchical relationships of genes in biological pathways. Bioinformatics. 2015; 31: 656–664.
doi: 10.1093/bioinformatics/btu727 PMID: 25359893
26. Zeller T, Wild P, Szymczak S, Rotival M, Schillert A, Castagne R, et al. Genetics and beyond—the tran-
scriptome of humanmonocytes and disease susceptibility. PLoS ONE. 2010; 5: e10693. doi: 10.1371/
journal.pone.0010693 PMID: 20502693
Gene Expression Profiles Associated with Non-Progression towards AIDS
PLOSONE | DOI:10.1371/journal.pone.0136989 September 14, 2015 11 / 13
27. Dixon AL, Liang L, Moffatt MF, ChenW, Heath S, Wong KCC, et al. A genome-wide association study
of global gene expression. Nat Genet. 2007; 39: 1202–1207. doi: 10.1038/ng2109 PMID: 17873877
28. Dimas AS, Deutsch S, Stranger BE, Montgomery SB, Borel C, Attar-Cohen H, et al. Common regula-
tory variation impacts gene expression in a cell type-dependent manner. Science. 2009; 325: 1246–
1250. doi: 10.1126/science.1174148 PMID: 19644074
29. Stranger BE, Forrest MS, Clark AG, Minichiello MJ, Deutsch S, Lyle R, et al. Genome-wide associa-
tions of gene expression variation in humans. PLoS Genet. 2005; 1: e78. doi: 10.1371/journal.pgen.
0010078 PMID: 16362079
30. Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, Thorne N, et al. Relative impact of nucleo-
tide and copy number variation on gene expression phenotypes. Science. 2007; 315: 848–853. doi: 10.
1126/science.1136678 PMID: 17289997
31. Van Manen D, Delaneau O, Kootstra NA, Boeser-Nunnink BD, Limou S, Bol SM, et al. Genome-wide
association scan in HIV-1-infected individuals identifying variants influencing disease course. PLoS
ONE. 2011; 6: e22208. doi: 10.1371/journal.pone.0022208 PMID: 21811574
32. Fellay J. Host genetics influences on HIV type-1 disease. Antivir Ther. 2009; 14: 731–738. doi: 10.
3851/IMP1253 PMID: 19812435
33. Chevalier MF, Weiss L. The split personality of regulatory T cells in HIV infection. Blood. 2013; 121: 29–
37. doi: 10.1182/blood-2012-07-409755 PMID: 23043072
34. Morou AK, Porichis F, Krambovitis E, Sourvinos G, Spandidos DA, Zafiropoulos A. The HIV-1 gp120/
V3 modifies the response of uninfected CD4 T cells to antigen presentation: mapping of the specific
transcriptional signature. J Transl Med. 2011; 9: 160. doi: 10.1186/1479-5876-9-160 PMID: 21943198
35. WilhelmM, Schlegl J, Hahne H, Gholami AM, Lieberenz M, Savitski MM, et al. Mass-spectrometry-
based draft of the human proteome. Nature. 2015; 509: 582–587. doi: 10.1038/nature13319
36. Guzmán-Fulgencio M, Jiménez JL, García-Álvarez M, Bellón JM, Fernández-Rodriguez A, Campos Y,
et al. Mitochondrial haplogroups are associated with clinical pattern of AIDS progression in HIV-infected
patients. J Acquir Immune Defic Syndr. 2013; 63: 178–183. PMID: 23666137
37. Hendrickson SL, Hutcheson HB, Ruiz-Pesini E, Poole JC, Lautenberger J, Sezgin E, et al. Mitochon-
drial DNA haplogroups influence AIDS progression. AIDS. 2008; 22: 2429–2439. PMID: 19005266
38. Huang T, Xu Z, Chen L, Cai Y-D, Kong X. Computational analysis of HIV-1 resistance based on gene
expression profiles and the virus-host interaction network. PLoS ONE. 2011; 6: e17291. doi: 10.1371/
journal.pone.0017291 PMID: 21394196
39. Wu JQ, Dwyer DE, Dyer WB, Yang YH, Wang B, Saksena NK. Genome-wide analysis of primary CD4+
and CD8+ T cell transcriptomes shows evidence for a network of enriched pathways associated with
HIV disease. Retrovirology. 2011; 8: 18. doi: 10.1186/1742-4690-8-18 PMID: 21410942
40. Urano E, Morikawa Y, Komano J. Novel Role of HSP40/DNAJ in the Regulation of HIV-1 Replication. J
Acquir Immune Defic Syndr. 2013; 64: 154–162. PMID: 24047968
41. Anderson I, Low JS, Weston S, Weinberger M, Zhyvoloup A, Labokha AA, et al. Heat shock protein 90
controls HIV-1 reactivation from latency. Proc Natl Acad Sci USA. 2014; 111: E1528–37. doi: 10.1073/
pnas.1320178111 PMID: 24706778
42. Low JS, Fassati A. Hsp90: a chaperone for HIV-1. Parasitology. 2014; 141: 1192–1202. doi: 10.1017/
S0031182014000298 PMID: 25004926
43. Cintron NS, Toft D. Defining the requirements for Hsp40 and Hsp70 in the Hsp90 chaperone pathway.
J Biol Chem. 2006; 281: 26235–26244. doi: 10.1074/jbc.M605417200 PMID: 16854979
44. Breuer K, Foroushani AK, Laird MR, Chen C, Sribnaia A, Lo R, et al. InnateDB: systems biology of
innate immunity and beyond—recent updates and continuing curation. Nucleic Acids Res. 2013; 41:
D1228–33. doi: 10.1093/nar/gks1147 PMID: 23180781
45. Ako-Adjei D, FuW, Wallin C, Katz KS, Song G, Darji D, et al. HIV-1, human interaction database: cur-
rent status and new features. Nucleic Acids Res. 2015; 43: D566–70. doi: 10.1093/nar/gku1126 PMID:
25378338
46. Banerjee S, Liao L, Russo R, Nakamura T, McKercher SR, Okamoto S-I, et al. Isobaric tagging-based
quantification by mass spectrometry of differentially regulated proteins in synaptosomes of HIV/gp120
transgenic mice: implications for HIV-associated neurodegeneration. Exp Neurol. 2012; 236: 298–306.
doi: 10.1016/j.expneurol.2012.04.013 PMID: 22575597
47. Plant K, Fairfax BP, Makino S, Vandiedonck C, Radhakrishnan J, Knight JC. Fine mapping genetic
determinants of the highly variably expressed MHC gene ZFP57. Eur J HumGenet. 2014; 22: 568–
571. doi: 10.1038/ejhg.2013.244 PMID: 24193346
48. Fellay J, Ge D, Shianna KV, Colombo S, Ledergerber B, Cirulli ET, et al. Common genetic variation and
the control of HIV-1 in humans. PLoS Genet. 2009; 5: e1000791. doi: 10.1371/journal.pgen.1000791
PMID: 20041166
Gene Expression Profiles Associated with Non-Progression towards AIDS
PLOSONE | DOI:10.1371/journal.pone.0136989 September 14, 2015 12 / 13
49. Nguyen DG, Yin H, Zhou Y, Wolff KC, Kuhen KL, Caldwell JS. Identification of novel therapeutic targets
for HIV infection through functional genomic cDNA screening. Virology. 2007; 362: 16–25. doi: 10.
1016/j.virol.2006.11.036 PMID: 17257639
50. Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK, et al. Gene map of the extended
human MHC. Nat Rev Genet. 2004; 5: 889–899. doi: 10.1038/nrg1489 PMID: 15573121
51. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, et al. Finding the missing herita-
bility of complex diseases. Nature. 2009; 461: 747–753. doi: 10.1038/nature08494 PMID: 19812666
52. Rappaport J, Cho YY, Hendel H, Schwartz EJ, Schächter F, Zagury J-F. 32 bpCCR-5 gene deletion
and resistance to fast progression in HIV-1 infected heterozygotes. Lancet. 1997; 349: 922–923. doi:
10.1016/S0140-6736(05)62697-9 PMID: 9093257
53. Van Manen D, Kootstra NA, Boeser-Nunnink B, Handulle MA, van’t Wout AB, Schuitemaker H. Associ-
ation of HLA-C andHCP5 gene regions with the clinical course of HIV-1 infection. AIDS. 2009; 23: 19–
28. PMID: 19050382
54. The 1000 Genomes Project Consortium. An integrated map of genetic variation from 1,092 human
genomes. Nature. 2012; 491: 56–65. doi: 10.1038/nature11632 PMID: 23128226
Gene Expression Profiles Associated with Non-Progression towards AIDS
PLOSONE | DOI:10.1371/journal.pone.0136989 September 14, 2015 13 / 13
